• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Contact Us
  • About Towleroad
  • Towleroad on Social Media
  • Privacy Policy

Towleroad Gay News

Gay Blog Towleroad: More than gay news | gay men

  • Travel
  • Sports
  • Law/Justice
  • Celebrities
  • Republicans
  • Madonna
  • Books
  • Men
  • Trans Rights
  • Royals
  • Monkeypox
  • Madonna SLAMS Haters Of Her ‘Unrecognizable’ Face At The Grammys: ‘You Won’t Break My Soul’
  • Judge denies DeSantis’ request for ‘mental examinations’ for minors seeking gender-affirming care
  • ‘Habibi’ beams light onto queer love in the Arab region

Ex-Hedge Funder Jacks Price of AIDS Drug Daraprim from $13.50 to $750 per Tablet

Andy Towle September 21, 2015 Leave a Comment

Martin Shkreli
Martin shkreli, ceo and founder of turing pharmaceuticals.

Martin Shkreli, the founder and CEO of Turing Pharmaceuticals and a former hedge fund manager, is under fire for hiking the price of Daraprim, a drug used to help (among others) AIDS patients with compromised immune systems, from $13.50 a tablet to $750 per tablet, a 5,455% increase.

Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing on the same day as the pricejacking.

The NYT reports:

Martin Shkreli, the founder and chief executive of Turing, said that the drug is so rarely used that the impact on the health system would be minuscule and that Turing would use the money it earns to develop better treatments for toxoplasmosis, with fewer side effects.

“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Mr. Shkreli said. He said that many patients use the drug for far less than a year and that the price was now more in line with those of other drugs for rare diseases.

“This is still one of the smallest pharmaceutical products in the world,” he said. “It really doesn’t make sense to get any criticism for this.”

Shkreli started Turing Pharmaceuticals, Daily Kos reports, “after a stint in his 20s as a hedge fund manager who shorted the stocks of pharmaceutical companies, and then tried to insert himself in the Food and Drug Administration’s approval process when drugs made by the companies he was shorting were being considered for approval.”

They add:

Now, you are probably wondering, why do our leaders let profiteers like Shkreli get way with this nonsense? The answer is that we are the only major country in the world that does not negotiate drug prices for all of our people. In Italy or France or Canada or Denmark or Germany, the government sits down with drug companies and says, “we will only pay you this much money for your drug in our country. Take it or leave it!” In the United States, Medicare — our single-payer program for those 65 and older who consume the majority of drugs in this country — is legally barred from negotiating lower drug prices. The American taxpayers must literally pay the price that Turing or Pfizer or any other drug company demands. It’s blackmail. It’s extortion.

DailyKos also notes that the only candidate with a solution to this problem is Bernie Sanders.

He has been speaking out about this problem — clearly and explicitly — throughout the campaign thus far.

Second, he has a solution — replace thousands of different private health insurance plans hopelessly “negotiating” with giant pharmaceutical companies for lower drug prices with one strong, robust single-payer.

Let me be clear: there is no Hillary Clinton-classic-Democratic Party-style kludge to punish the Shkreli-style greed.

Indeed, Shkreli’s company is very careful to provide free drugs — and highly-discounted drugs — to low-income patients. Shrkeli isn’t in the business of ripping off individual sick people (well, he kind of is…), but is in the much-larger business of ripping off the United States Government, and the taxpayers who finance that government.

Meanwhile, patients will suffer:

Daraprim is the standard first treatment for toxoplasmosis, in combination with an antibiotic called sulfadiazine. There are alternative treatments, but there is less data supporting their efficacy.

Dr. Aberg of Mount Sinai said some hospitals will now find Daraprim too expensive to keep in stock, possibly resulting in treatment delays.

Top image: Twitter via Raw Story.

Topics: Business, Health More Posts About: AIDS, AIDS/HIV, Health, Martin Shkreli, Medicine

Related Posts
  • Studio 54 owner Mark Fleischman dies by assisted suicide at Dignitas, says his business partner
  • Govt’s Halting Response In Ramping Monkeypox Tests, Vaccines May Have Missed Chance to Contain Outbreak Over Last 30 Days.
  • MPX is MonkeyPox is Everywhere; CDC Undercounts Cases; ‘Lesions, Headaches, Debilitating Pain… You Don’t Want This ‘; ROUNDUP
  • Judge denies DeSantis’ request for ‘mental examinations’ for minors seeking gender-affirming care

    Judge denies DeSantis’ request for ‘mental examinations’ for minors seeking gender-affirming care

    Published by AlterNet A federal judge ruled against Florida Governor Ron DeSantis’ request for minors seeking gender-affirming treatment to be subjected to two-hour mental examinations, Orlando Weekly reports. The ruling from U.S. District Judge Robert Hinkle …Read More »
  • ‘Habibi’ beams light onto queer love in the Arab region

    ‘Habibi’ beams light onto queer love in the Arab region

    Published by Al-Araby In a colourful setting on level -1 of the Arab World Institute (IMA) in the heart of Paris, installations, videos, paintings, drawings, designs and embroideries are showcased until February 19 under the title …Read More »
  • Christina Aguilera and Bad Bunny to be honoured at GLAAD Media Awards

    Christina Aguilera and Bad Bunny to be honoured at GLAAD Media Awards

    Published by BANG Showbiz English Christina Aguilera, Bad Bunny and Jeremy Pope will be honoured at the GLAAD Media Awards. The trio will be recognised for their contribution to the LGBTQ community at the ceremony that …Read More »
  • Bret Easton Ellis returns with ‘The Shards’ – dark autofiction

    Bret Easton Ellis returns with ‘The Shards’ – dark autofiction

    Published by DPA Bret Easton Ellis, the cult author behind "American Psycho", is back with a massive novel about wealthy teenagers, a mysterious newcomer student and a serial killer, all narrated by a teen who shares …Read More »
Previous Post: « FOX News’ Megyn Kelly to Interview Kim Davis; ‘Good Morning America’ Too
Next Post: News: Twin Peaks, Pope Francis, Major Lazer, Grace Jones, NYC »

Primary Sidebar

Adjacent News

  • ‘Most disrespectful bill’ — Missouri lawmakers push to ban teachers from discussing LGBTQ identity

    ‘Most disrespectful bill’ — Missouri lawmakers push to ban teachers from discussing LGBTQ identity

  • First gay married vicar attacks Church of England’s same-sex marriage blessing rule

    First gay married vicar attacks Church of England’s same-sex marriage blessing rule

  • European cost of living crisis: Berlin paying young people to go clubbing

    European cost of living crisis: Berlin paying young people to go clubbing

Good Trash: Going to Read It Somewhere, Y'know

  • ‘At Least You Know I’m Singing Live’: Adele FORGETS The Lyrics To Her Award-Winning Song At Las Vegas Residency Before Grammys

    ‘At Least You Know I’m Singing Live’: Adele FORGETS The Lyrics To Her Award-Winning Song At Las Vegas Residency Before Grammys

  • ‘Leaving Neverland’ Director SLAMS Michael Jackson Biopic Starring Late King Of Pop’s Nephew, Claiming It Will ‘Glorify A Pedophile’

    ‘Leaving Neverland’ Director SLAMS Michael Jackson Biopic Starring Late King Of Pop’s Nephew, Claiming It Will ‘Glorify A Pedophile’

  • Sarah Michelle Gellar reveals Sandy Gallin and Dolly Parton’s ‘little known’ Buffy the Vampire Slayer role

    Sarah Michelle Gellar reveals Sandy Gallin and Dolly Parton’s ‘little known’ Buffy the Vampire Slayer role

RSS Partner Links

  • Lily Collins Opens Up About Toxic Relationship with Ex who Called Her a 'Whore'
  • Michael Jackson’s Estate Is Closing In On A Deal To Sell Half Of Its Stake In His Music Catalog For Almost $1 Billion
  • A Judge Shut Down A Request From Wendy Williams’ Ex Kevin Hunter To Resume Alimony Payments
  • Iowa GOP Wants To Let 14-Year-Olds Drive To Their Job In The Mines
  • Celebrity 'Great British Bake Off' 2023 Cast Revealed!
  • Pink Explains Her Love for Aerial Stunts, Opens Up About the Loss of Her Father & Going to a Wellness Clinic in 'Women's Health' Interview
  • OMG, DC’s trans non-binary character has arrived

Most Recent

  • Madonna SLAMS Haters Of Her ‘Unrecognizable’ Face At The Grammys: ‘You Won’t Break My Soul’

    Madonna SLAMS Haters Of Her ‘Unrecognizable’ Face At The Grammys: ‘You Won’t Break My Soul’

  • Judge denies DeSantis’ request for ‘mental examinations’ for minors seeking gender-affirming care

    Judge denies DeSantis’ request for ‘mental examinations’ for minors seeking gender-affirming care

  • ‘Habibi’ beams light onto queer love in the Arab region

    ‘Habibi’ beams light onto queer love in the Arab region

  • Christina Aguilera and Bad Bunny to be honoured at GLAAD Media Awards

    Christina Aguilera and Bad Bunny to be honoured at GLAAD Media Awards

  • Bret Easton Ellis returns with ‘The Shards’ – dark autofiction

    Bret Easton Ellis returns with ‘The Shards’ – dark autofiction

  • Indigo Girls in “Protect Trans Kids” T-shirt Are More Than “Fine” At Tiny Desk Show; And Queer Playlist From 10 Years of NPR Concerts:  WATCH

    Indigo Girls in “Protect Trans Kids” T-shirt Are More Than “Fine” At Tiny Desk Show; And Queer Playlist From 10 Years of NPR Concerts: WATCH

  • Dexter Origins confirmed with plans for more serial killer spin offs

    Dexter Origins confirmed with plans for more serial killer spin offs

  • Retired, Single & Sexy! Tom Brady Holds His Hand Over His Private Parts In Nearly Nude Selfie — See Photo

    Retired, Single & Sexy! Tom Brady Holds His Hand Over His Private Parts In Nearly Nude Selfie — See Photo

Most Commented

Social

Twitter @tlrd | Facebook | Instagram @tlrd

Footer

Copyright © 2023 · Log in

×